| __timestamp | Amneal Pharmaceuticals, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 335989000 | 60987000 |
| Thursday, January 1, 2015 | 367054000 | 125542000 |
| Friday, January 1, 2016 | 420770000 | 210460000 |
| Sunday, January 1, 2017 | 507476000 | 275119000 |
| Monday, January 1, 2018 | 946588000 | 409539000 |
| Tuesday, January 1, 2019 | 1273376000 | 547758000 |
| Wednesday, January 1, 2020 | 1364130000 | 736300000 |
| Friday, January 1, 2021 | 1324696000 | 904200000 |
| Saturday, January 1, 2022 | 1427596000 | 1080300000 |
| Sunday, January 1, 2023 | 1573042000 | 1262200000 |
| Monday, January 1, 2024 | 1530500000 |
In pursuit of knowledge
In the competitive landscape of pharmaceuticals, cost efficiency is paramount. This analysis delves into the cost of revenue trends for Vertex Pharmaceuticals Incorporated and Amneal Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Amneal's cost of revenue surged by approximately 368%, peaking in 2023. In contrast, Vertex demonstrated a more moderate increase of around 196%, reflecting a strategic approach to cost management.
This decade-long comparison highlights the dynamic strategies of these industry players, offering valuable insights into their financial health and operational efficiency.
Cost of Revenue: Key Insights for Sanofi and Amneal Pharmaceuticals, Inc.
Cost of Revenue Trends: Vertex Pharmaceuticals Incorporated vs BioMarin Pharmaceutical Inc.
Analyzing Cost of Revenue: Vertex Pharmaceuticals Incorporated and PTC Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs MorphoSys AG
Cost of Revenue: Key Insights for Vertex Pharmaceuticals Incorporated and Vericel Corporation
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Ligand Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Amneal Pharmaceuticals, Inc.
ADMA Biologics, Inc. vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs CRISPR Therapeutics AG
Amneal Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Amneal Pharmaceuticals, Inc. and Wave Life Sciences Ltd.